William Raj Sellers, M.D.
Affiliations: | Novartis, Basel, Basel-Stadt, France | ||
Dana-Farber Cancer Institute and Harvard Medical School, USA | |||
Broad Institute - Cancer Program |
Area:
oncologyGoogle:
"William Sellers"Mean distance: 19.98 (cluster 51)
Children
Sign in to add traineeLevi A. Garraway | grad student | Dana-Farber Cancer Institute and Harvard Medical School (Cell Biology Tree) | |
Jordi Barretina | post-doc | Dana-Farber Cancer Institute | |
Derek Yung-Ho Chiang | post-doc | Dana-Farber Cancer Institute (FlyTree) | |
Laurens Moore van Tienen | post-doc | ||
Rameen Beroukhim | post-doc | 2003-2006 | Dana-Farber Cancer Institute |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chang L, Jung NY, Atari A, et al. (2023) Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities. Nature Genetics |
Tiedt R, King FJ, Stamm C, et al. (2023) Integrated CRISPR screening and drug profiling identifies combination opportunities for EGFR, ALK, and BRAF/MEK inhibitors. Cell Reports. 42: 112297 |
Bondeson DP, Mullin-Bernstein Z, Oliver S, et al. (2022) Systematic profiling of conditional degron tag technologies for target validation studies. Nature Communications. 13: 5495 |
Cantor SB, Sellers WR, Pathania S, et al. (2022) David Livingston (1941-2021). Molecular Cell. 82: 4-7 |
Ito T, Young MJ, Li R, et al. (2021) Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. Nature Genetics |
LaMarche MJ, Acker MG, Argintaru A, et al. (2020) Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry |
Palmer AC, Plana D, Gao H, et al. (2020) A proof of concept for biomarker-guided targeted therapy against ovarian cancer based on patient-derived tumor xenografts. Cancer Research |
Nusinow DP, Szpyt J, Ghandi M, et al. (2020) Quantitative Proteomics of the Cancer Cell Line Encyclopedia. Cell. 180: 387-402.e16 |
Cleary JM, Raghavan S, Li YY, et al. (2020) Therapeutic targeting of extracellular FGFR2 activating deletions in intrahepatic cholangiocarcinoma. Journal of Clinical Oncology. 38: 567-567 |
Wernitznig A, Lipp JJ, Zichner T, et al. (2020) Abstract 3227: CLIFF, a bioinformatics software tool to explore molecular differences between two sets of cancer cell lines Cancer Research. 80: 3227-3227 |